{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:15:05Z","timestamp":1790036105127,"version":"4.0.1"},"reference-count":197,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ajpc.2025.100928","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T07:28:05Z","timestamp":1739950085000},"page":"100928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Underpinnings of heart failure with preserved ejection fraction in women - From prevention to improving function. A co-publication with the American Journal of Preventive Cardiology and the Journal of Cardiac Failure"],"prefix":"10.1016","volume":"23","author":[{"given":"Ankitha","family":"Radakrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saloni","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nausheen","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslee J.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0735-9756","authenticated-orcid":false,"given":"Martha","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Lala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2025.100928_bib0001","unstructured":"Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America - ClinicalKey. Accessed April 2, 2024. https:\/\/www.clinicalkey.com\/#!\/content\/playContent\/1-s2.0-S1071916423002646?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1071916423002646%3Fshowall%3Dtrue&referrer=https:%2F%2Fpubmed.ncbi.nlm.nih.gov%2F."},{"issue":"4","key":"10.1016\/j.ajpc.2025.100928_bib0002","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","volume":"27","author":"Bozkurt","year":"2021","journal-title":"J Card Fail"},{"issue":"1","key":"10.1016\/j.ajpc.2025.100928_bib0003","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCULATIONAHA.116.021884","article-title":"Phenotype-specific treatment of heart failure with preserved ejection fraction","volume":"134","author":"Shah","year":"2016","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ajpc.2025.100928_bib0004","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"Dunlay","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"17","key":"10.1016\/j.ajpc.2025.100928_bib0005","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1161\/CIRCULATIONAHA.117.031622","article-title":"Sex and race differences in lifetime risk of heart failure with preserved ejection fraction and heart failure with reduced ejection fraction","volume":"137","author":"Pandey","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ajpc.2025.100928_bib0006","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ajpc.2025.100928_bib0007","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006539","article-title":"Sex-related differences in heart failure with preserved ejection fraction","volume":"12","author":"Dewan","year":"2019","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.ajpc.2025.100928_bib0008","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.hfc.2018.08.002","article-title":"Heart failure with preserved ejection fraction in women","volume":"15","author":"Tibrewala","year":"2019","journal-title":"Heart Fail Clin"},{"issue":"2","key":"10.1016\/j.ajpc.2025.100928_bib0009","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejheart.2007.12.012","article-title":"Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II","volume":"10","author":"Nieminen","year":"2008","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100928_bib0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ejhf.67","article-title":"Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction","volume":"16","author":"Gori","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.ajpc.2025.100928_bib0011","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jchf.2019.01.004","article-title":"Sex differences in heart failure with preserved ejection fraction pathophysiology","volume":"7","author":"Beale","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"10","key":"10.1016\/j.ajpc.2025.100928_bib0012","first-page":"S132","article-title":"The sympomatic tipping point: factors that prompt men and women to seek medical care","volume":"30","author":"Kreatsoulas","year":"2014","journal-title":"Can J Cardiol"},{"issue":"9","key":"10.1016\/j.ajpc.2025.100928_bib0013","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/archinte.168.9.959","article-title":"Factors associated with longer time from symptom onset to hospital presentation for patients with ST-elevation myocardial infarction","volume":"168","author":"Ting","year":"2008","journal-title":"Arch Intern Med"},{"issue":"18","key":"10.1016\/j.ajpc.2025.100928_bib0014","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart failure with preserved ejection fraction: JACC scientific statement","volume":"81","author":"Borlaug","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.100928_bib0015","article-title":"Sex differences in heart failure with preserved ejection fraction: from traditional risk factors to sex-specific risk factors","volume":"18","author":"Kaur","year":"2022","journal-title":"Womens Health"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100928_bib0016","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.amepre.2023.05.011","article-title":"Sex differences in cardiovascular risk associated with prediabetes and undiagnosed diabetes","volume":"65","author":"Yoshida","year":"2023","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ajpc.2025.100928_bib0017","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.atherosclerosis.2021.06.909","article-title":"Smoking and sex differences in first manifestation of cardiovascular disease","volume":"330","author":"Vasiljevic","year":"2021","journal-title":"Atherosclerosis"},{"issue":"9403","key":"10.1016\/j.ajpc.2025.100928_bib0018","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"The Lancet"},{"key":"10.1016\/j.ajpc.2025.100928_bib0019","article-title":"Defining adult overweight and obesity","year":"2024","journal-title":"Center Dis Control Prevent"},{"key":"10.1016\/j.ajpc.2025.100928_bib0020","unstructured":"Overweight & Obesity Statistics - NIDDK. National institute of diabetes and digestive and kidney diseases. Accessed May 7, 2024. https:\/\/www.niddk.nih.gov\/health-information\/health-statistics\/overweight-obesity."},{"key":"10.1016\/j.ajpc.2025.100928_bib0021","unstructured":"Products - Data Briefs - Number 360 - February 2020. June 26, 2020. Accessed May 7, 2024. https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db360.htm."},{"key":"10.1016\/j.ajpc.2025.100928_bib0022","doi-asserted-by":"crossref","DOI":"10.5888\/pcd14.160573","article-title":"Beyond body mass index: are weight-loss programs the best way to improve the health of African American women?","volume":"14","author":"Dodgen","year":"2017","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.ajpc.2025.100928_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.00022","article-title":"Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease","volume":"7","author":"Chait","year":"2020","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"10.1016\/j.ajpc.2025.100928_bib0024","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41574-019-0230-6","article-title":"The endocrine function of adipose tissues in health and cardiometabolic disease","volume":"15","author":"Scheja","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ajpc.2025.100928_bib0025","article-title":"Associations of visceral adipose tissue, circulating protein biomarkers, and risk of cardiovascular diseases: a mendelian randomization analysis","volume":"10","author":"Huang","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"10.1016\/j.ajpc.2025.100928_bib0026","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3390\/biom10030374","article-title":"The role of secretory activity molecules of visceral adipocytes in abdominal obesity in the development of cardiovascular disease: a review","volume":"10","author":"Ragino","year":"2020","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.ajpc.2025.100928_bib0027","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/edrv.21.6.0415","article-title":"Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome","volume":"21","author":"Wajchenberg","year":"2000","journal-title":"Endocr Rev"},{"issue":"9","key":"10.1016\/j.ajpc.2025.100928_bib0028","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/ejhf.1902","article-title":"Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease","volume":"22","author":"Packer","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.ajpc.2025.100928_bib0029","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jchf.2020.04.016","article-title":"Hemodynamic and functional impact of epicardial adipose tissue in heart failure with preserved ejection fraction","volume":"8","author":"Koepp","year":"2020","journal-title":"JACC Heart Fail"},{"issue":"11","key":"10.1016\/j.ajpc.2025.100928_bib0030","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/ejhf.1283","article-title":"Epicardial fat in heart failure patients with mid-range and preserved ejection fraction","volume":"20","author":"van Woerden","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.ajpc.2025.100928_bib0031","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ejhf.1617","article-title":"Myocardial adipose deposition and the development of heart failure with preserved ejection fraction","volume":"22","author":"Wu","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100928_bib0032","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/ejhf.2156","article-title":"Epicardial fat in heart failure with reduced versus preserved ejection fraction","volume":"23","author":"Tromp","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.ajpc.2025.100928_bib0033","first-page":"397","article-title":"Epicardial adiposity in relation to metabolic abnormality, circulating adipocyte FABP, and preserved ejection fraction heart failure","volume":"11","author":"Lin","year":"2021","journal-title":"Diagn Basel Switz"},{"issue":"11","key":"10.1016\/j.ajpc.2025.100928_bib0034","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/ejhf.2337","article-title":"Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure","volume":"23","author":"Pugliese","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.ajpc.2025.100928_bib0035","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/ejhf.2513","article-title":"Epicardial adipose tissue related to left atrial and ventricular function in heart failure with preserved versus reduced and mildly reduced ejection fraction","volume":"24","author":"Jin","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.ajpc.2025.100928_bib0036","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jchf.2018.07.009","article-title":"Adiposity and incident heart failure and its subtypes","volume":"6","author":"Rao","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"12","key":"10.1016\/j.ajpc.2025.100928_bib0037","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/ejhf.2741","article-title":"Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectives","volume":"24","author":"van Woerden","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.ajpc.2025.100928_bib0038","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/ehf2.14419","article-title":"Association of perivascular fat attenuation on computed tomography and heart failure with preserved ejection fraction","volume":"10","author":"Nishihara","year":"2023","journal-title":"ESC Heart Fail"},{"issue":"16","key":"10.1016\/j.ajpc.2025.100928_bib0039","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/eurheartj\/ehaa823","article-title":"Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction","volume":"42","author":"Sorimachi","year":"2021","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.ajpc.2025.100928_bib0040","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/j.jacc.2017.04.016","article-title":"Obesity-related changes in cardiac structure and function among Asian men and women","volume":"69","author":"Lai","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ajpc.2025.100928_bib0041","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/oby.23639","article-title":"Obesity among Asian American people in the United States : a review","volume":"31","author":"Li","year":"2023","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.ajpc.2025.100928_bib0042","doi-asserted-by":"crossref","first-page":"16404","DOI":"10.1038\/s41598-021-95777-y","article-title":"Secular trends in the prevalence of abdominal obesity among Chinese adults with normal weight, 1993\u20132015","volume":"11","author":"Sun","year":"2021","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.ajpc.2025.100928_bib0043","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/ejhf.2563","article-title":"Sex and central obesity in heart failure with preserved ejection fraction","volume":"24","author":"Sorimachi","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100928_bib0044","doi-asserted-by":"crossref","first-page":"H2031","DOI":"10.1152\/ajpheart.01058.2004","article-title":"Adipokines: molecular links between obesity and atheroslcerosis","volume":"288","author":"Lau","year":"2005","journal-title":"Am J Physiol-Heart Circ Physiol"},{"issue":"6","key":"10.1016\/j.ajpc.2025.100928_bib0045","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s10741-017-9644-1","article-title":"Epicardial adipose tissue as a metabolic transducer: role in heart failure and coronary artery disease","volume":"22","author":"Patel","year":"2017","journal-title":"Heart Fail Rev"},{"issue":"2","key":"10.1016\/j.ajpc.2025.100928_bib0046","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.ajpc.2025.100928_bib0047","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jchf.2018.08.007","article-title":"Pivotal role of excess intra-abdominal adipose in the pathogenesis of metabolic\/obese HFpEF\u2217","volume":"6","author":"Kitzman","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"2","key":"10.1016\/j.ajpc.2025.100928_bib0048","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jcmg.2023.07.014","article-title":"Body composition, coronary microvascular dysfunction, and future risk of cardiovascular events including heart failure","volume":"17","author":"Souza","year":"2024","journal-title":"JACC Cardiovasc Imag"},{"issue":"8","key":"10.1016\/j.ajpc.2025.100928_bib0049","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jchf.2018.01.009","article-title":"Obesity-related heart failure with a preserved ejection fraction","volume":"6","author":"Packer","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"10","key":"10.1016\/j.ajpc.2025.100928_bib0050","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1210\/clinem\/dgad193","article-title":"Sex-specific association between adipose tissue inflammation and vascular and metabolic complications of obesity","volume":"108","author":"Cossins","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ajpc.2025.100928_bib0051","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41366-023-01444-9","article-title":"Sex-specific association of visceral and subcutaneous adipose tissue volumes with systemic inflammation and innate immune cells in people living with obesity","volume":"48","author":"van den Munckhof","year":"2024","journal-title":"Int J Obes"},{"issue":"1","key":"10.1016\/j.ajpc.2025.100928_bib0052","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12902-023-01396-1","article-title":"Threshold effect and sex characteristics of the relationship between chronic inflammation and BMI","volume":"23","author":"Liqiang","year":"2023","journal-title":"BMC Endocr Disord"},{"issue":"11","key":"10.1016\/j.ajpc.2025.100928_bib0053","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010618","article-title":"Obesity-related biomarkers are associated with exercise intolerance and HFpEF","volume":"16","author":"Ramirez","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ajpc.2025.100928_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.131818","article-title":"High-sensitivity C-reactive protein in heart failure with preserved ejection fraction: findings from TOPCAT","volume":"402","author":"Ferreira","year":"2024","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ajpc.2025.100928_bib0055","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.2147\/JIR.S459989","article-title":"Prognostic value of inflammatory cytokines in predicting hospital readmissions in heart failure with preserved ejection fraction","volume":"17","author":"Zhao","year":"2024","journal-title":"J Inflamm Res"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100928_bib0056","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","article-title":"Reappraising the role of inflammation in heart failure","volume":"17","author":"Adamo","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2025.100928_bib0057","doi-asserted-by":"crossref","first-page":"34","DOI":"10.18087\/cardio.2024.3.n2534","article-title":"Interleukin 6 signalling in heart failure with preserved and reduced ejection fraction","volume":"64","author":"Samoilova","year":"2024","journal-title":"Kardiologiia"},{"issue":"11","key":"10.1016\/j.ajpc.2025.100928_bib0058","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jchf.2023.06.031","article-title":"Interleukin-6 in patients with heart failure and preserved ejection fraction","volume":"11","author":"Alogna","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ajpc.2025.100928_bib0059","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.928232","article-title":"Current understanding of molecular pathophysiology of heart failure with preserved ejection fraction","volume":"13","author":"Budde","year":"2022","journal-title":"Front Physiol"},{"issue":"22","key":"10.1016\/j.ajpc.2025.100928_bib0060","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1161\/CIRCULATIONAHA.115.018226","article-title":"Adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction and cardiac fibrosis","volume":"132","author":"Huby","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100928_bib0061","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.190223","article-title":"Adipocytes produce aldosterone through calcineurin-dependent signaling pathways","volume":"59","author":"Briones","year":"2012","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ajpc.2025.100928_bib0062","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct Obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.100928_bib0063","article-title":"Decreased left ventricular distensibility in response to postural change in older patients with heart failure and preserved ejection fraction","year":"2024","journal-title":"Am. J. Physiol.-Heart Circulat. Physiol."},{"issue":"1","key":"10.1016\/j.ajpc.2025.100928_bib0064","doi-asserted-by":"crossref","first-page":"14750","DOI":"10.1038\/s41598-021-94189-2","article-title":"Changes in abdominal subcutaneous adipose tissue phenotype following menopause is associated with increased visceral fat mass","volume":"11","author":"Abildgaard","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpc.2025.100928_bib0065","unstructured":"C.D.C. National Diabetes Statistics Report. Diabetes. May 13, 2024. Accessed May 16, 2024. https:\/\/www.cdc.gov\/diabetes\/php\/data-research\/index.html."},{"issue":"1","key":"10.1016\/j.ajpc.2025.100928_bib0066","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100928_bib0067","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjac028","article-title":"Heart failure with preserved ejection fraction (HFpEF) in type 2 diabetes mellitus: from pathophysiology to therapeutics","volume":"14","author":"Abudureyimu","year":"2022","journal-title":"J Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.ajpc.2025.100928_bib0068","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s00125-023-05891-x","article-title":"Sex differences in type 2 diabetes","volume":"66","author":"Kautzky-Willer","year":"2023","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100928_bib0069","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jacc.2018.11.033","article-title":"Heart failure with preserved ejection fraction and diabetes","volume":"73","author":"McHugh","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ajpc.2025.100928_bib0070","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ajpc.2025.100928_bib0071","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.amjcard.2009.09.041","article-title":"Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus","volume":"105","author":"Aguilar","year":"2010","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ajpc.2025.100928_bib0072","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jacc.2014.05.030","article-title":"Cardiovascular phenotype in HFpEF patients with or without diabetes","volume":"64","author":"Lindman","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ajpc.2025.100928_bib0073","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.116.024593","article-title":"Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction","volume":"135","author":"Kristensen","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ajpc.2025.100928_bib0074","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jacc.2024.05.036","article-title":"The Quest for understanding diabetic cardiomyopathy","volume":"84","author":"Lala","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.100928_bib0075","unstructured":"Clinical update: cardiovascular disease in diabetes mellitus | circulation. Accessed May 10, 2024. https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCULATIONAHA.116.022194."},{"key":"10.1016\/j.ajpc.2025.100928_bib0076","unstructured":"Low myocardial protein kinase G activity in heart failure with preserved ejection fraction | circulation. Accessed May 10, 2024. https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCULATIONAHA.111.076075."},{"issue":"1","key":"10.1016\/j.ajpc.2025.100928_bib0077","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0002-9149(91)90716-X","article-title":"Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study)","volume":"68","author":"Galderisi","year":"1991","journal-title":"Am J Cardiol"},{"issue":"24","key":"10.1016\/j.ajpc.2025.100928_bib0078","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.108.815944","article-title":"Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction","volume":"119","author":"Lee","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ajpc.2025.100928_bib0079","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00059-022-05123-9","article-title":"Comorbidities in heart failure with preserved ejection fraction","volume":"47","author":"Deichl","year":"2022","journal-title":"Herz"},{"key":"10.1016\/j.ajpc.2025.100928_bib0080","doi-asserted-by":"crossref","unstructured":"Goyal P., Paul T., Almarzooq Z.I., et al. Sex- and race-related differences in characteristics and outcomes of hospitalizations for heart failure with preserved ejection fraction. J Am Heart Assoc. 6(4):e003330. doi:10.1161\/JAHA.116.003330.","DOI":"10.1161\/JAHA.116.003330"},{"issue":"20","key":"10.1016\/j.ajpc.2025.100928_bib0081","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","article-title":"The progression from hypertension to congestive heart failure","volume":"275","author":"Levy","year":"1996","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ajpc.2025.100928_bib0082","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.100928_bib0083","unstructured":"Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment - Nauta - 2020 - European Journal of Heart Failure - Wiley Online Library. Accessed May 10, 2024. https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/ejhf.1632."},{"issue":"5","key":"10.1016\/j.ajpc.2025.100928_bib0084","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ejhf.67","article-title":"Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction","volume":"16","author":"Gori","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.ajpc.2025.100928_bib0085","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cardfail.2021.10.019","article-title":"Arterial stiffness and vascular load in HFpEF: differences among women and men","volume":"28","author":"Lau","year":"2022","journal-title":"J Card Fail"},{"issue":"11","key":"10.1016\/j.ajpc.2025.100928_bib0086","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/ajh\/hpt115","article-title":"Relationship between augmentation index and left ventricular diastolic function in healthy women and men","volume":"26","author":"Higashi","year":"2013","journal-title":"Am J Hypertens"},{"issue":"10","key":"10.1016\/j.ajpc.2025.100928_bib0087","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.amjcard.2017.07.089","article-title":"Usefulness of coronary artery calcium to predict heart failure with preserved ejection fraction in men versus women (from the Multi-Ethnic Study of Atherosclerosis)","volume":"120","author":"Sharma","year":"2017","journal-title":"Am J Cardiol"},{"issue":"37","key":"10.1016\/j.ajpc.2025.100928_bib0088","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","article-title":"Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: pROMIS-HFpEF","volume":"39","author":"Shah","year":"2018","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ajpc.2025.100928_bib0089","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.amjmed.2018.12.038","article-title":"Heart failure with preserved ejection fraction: is ischemia due to coronary microvascular dysfunction a mechanistic factor?","volume":"132","author":"Elgendy","year":"2019","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.ajpc.2025.100928_bib0090","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ejhf.1671","article-title":"Endothelium-dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction","volume":"22","author":"Yang","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100928_bib0091","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ejhf.2010","article-title":"Coronary microvascular dysfunction is associated with exertional haemodynamic abnormalities in patients with heart failure with preserved ejection fraction","volume":"23","author":"Ahmad","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.ajpc.2025.100928_bib0092","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","article-title":"Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events","volume":"33","author":"Jespersen","year":"2012","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.ajpc.2025.100928_bib0093","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1161\/CIRCULATIONAHA.107.726562","article-title":"Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and In-hospital mortality in the American College of Cardiology\u2013National cardiovascular data registry","volume":"117","author":"Shaw","year":"2008","journal-title":"Circulation"},{"issue":"37","key":"10.1016\/j.ajpc.2025.100928_bib0094","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1093\/eurheartj\/ehaa503","volume":"41","author":"Kunadian","year":"2020","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.ajpc.2025.100928_bib0095","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1161\/01.CIR.0000130642.79868.B2","article-title":"Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease","volume":"109","author":"Johnson","year":"2004","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.ajpc.2025.100928_bib0096","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/CIRCULATIONAHA.120.046791","article-title":"Natural history of patients with ischemia and No obstructive coronary artery disease","volume":"144","author":"Reynolds","year":"2021","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ajpc.2025.100928_bib0097","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","article-title":"Crea Filippo. Coronary microvascular dysfunction","volume":"356","author":"Camici Paolo","year":"2007","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ajpc.2025.100928_bib0098","doi-asserted-by":"crossref","first-page":"13471","DOI":"10.3390\/ijms222413471","article-title":"Inflammation in coronary microvascular dysfunction","volume":"22","author":"Sagris","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"14","key":"10.1016\/j.ajpc.2025.100928_bib0099","doi-asserted-by":"crossref","first-page":"11287","DOI":"10.3390\/ijms241411287","article-title":"Coronary \u201cmicrovascular dysfunction\u201d: evolving understanding of pathophysiology, clinical implications, and potential therapeutics","volume":"24","author":"Kei","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.ajpc.2025.100928_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100264","article-title":"Biomarkers and coronary microvascular dysfunction in women with angina and No obstructive coronary artery disease","volume":"2","author":"Prescott","year":"2023","journal-title":"JACC Adv"},{"issue":"9","key":"10.1016\/j.ajpc.2025.100928_bib0101","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/CIR.0000000000000351","article-title":"Acute myocardial infarction in women","volume":"133","author":"Mehta","year":"2016","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ajpc.2025.100928_bib0102","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/HYPERTENSIONAHA.124.22905","article-title":"Coronary microvascular function following severe preeclampsia","volume":"81","author":"Honigberg","year":"2024","journal-title":"Hypertension"},{"issue":"16","key":"10.1016\/j.ajpc.2025.100928_bib0103","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.jacc.2018.12.092","article-title":"Long-term cardiovascular risks associated with adverse pregnancy outcomes","volume":"73","author":"Lane-Cordova Abbi","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ajpc.2025.100928_bib0104","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/GME.0000000000001815","article-title":"Associations between menopause, cardiac remodeling, and diastolic function: the CARDIA study","volume":"28","author":"Ying","year":"2021","journal-title":"Menopause"},{"issue":"22","key":"10.1016\/j.ajpc.2025.100928_bib0105","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.jacc.2019.09.052","article-title":"Long-term cardiovascular risk in women with hypertension during pregnancy","volume":"74","author":"Honigberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ajpc.2025.100928_bib0106","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1210\/jc.2004-0015","article-title":"Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy","volume":"89","author":"Kalantaridou","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"10.1016\/j.ajpc.2025.100928_bib0107","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/jama.2014.14681","article-title":"Nonobstructive coronary artery disease and risk of myocardial infarction","volume":"312","author":"Maddox","year":"2014","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ajpc.2025.100928_bib0108","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/eurheartj\/ehx721","article-title":"Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction","volume":"39","author":"Taqueti","year":"2018","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ajpc.2025.100928_bib0109","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/archinternmed.2009.50","article-title":"Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the women's Ischemia Syndrome evaluation study and the St James Women take heart project","volume":"169","author":"Gulati","year":"2009","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.ajpc.2025.100928_bib0110","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archinte.161.7.996","article-title":"Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study","volume":"161","author":"He","year":"2001","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100928_bib0111","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/hr.2010.25","article-title":"The effect of smoking on arterial stiffness","volume":"33","author":"Doonan","year":"2010","journal-title":"Hypertens Res"},{"issue":"12","key":"10.1016\/j.ajpc.2025.100928_bib0112","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1136\/hrt.2006.088294","article-title":"Left ventricular growth response to exercise and cigarette smoking: data from LARGE Heart","volume":"92","author":"Payne","year":"2006","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ajpc.2025.100928_bib0113","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mrfmmm.2007.02.010","article-title":"The role of tobacco smoke induced mitochondrial damage in vascular dysfunction and atherosclerosis","volume":"621","author":"Yang","year":"2007","journal-title":"Mutat Res Mol Mech Mutagen"},{"issue":"11","key":"10.1016\/j.ajpc.2025.100928_bib0114","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.118.036259","article-title":"Mitochondrial dysfunction in heart failure with preserved ejection fraction","volume":"139","author":"Kumar","year":"2019","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ajpc.2025.100928_bib0115","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.amjcard.2019.03.015","article-title":"Relation between cigarette smoking and heart failure (From the Multi-Ethnic Study of Atherosclerosis)","volume":"123","author":"Watson","year":"2019","journal-title":"Am J Cardiol"},{"issue":"23","key":"10.1016\/j.ajpc.2025.100928_bib0116","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.jacc.2022.03.377","article-title":"Cigarette smoking, cessation, and risk of heart failure with preserved and reduced ejection fraction","volume":"79","author":"Ding","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2025.100928_bib0117","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jacbts.2020.02.001","article-title":"Heart failure with preserved ejection fraction in women","volume":"5","author":"Barton","year":"2020","journal-title":"JACC Basic Transl Sci"},{"issue":"7","key":"10.1016\/j.ajpc.2025.100928_bib0118","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1253\/circj.CJ-10-0196","article-title":"Sex and gender differences in myocardial hypertrophy and heart failure","volume":"74","author":"Regitz-Zagrosek","year":"2010","journal-title":"Circ J"},{"issue":"10","key":"10.1016\/j.ajpc.2025.100928_bib0119","doi-asserted-by":"crossref","first-page":"e3798","DOI":"10.1210\/clinem\/dgaa500","article-title":"Sex hormones and incident heart failure in men and postmenopausal women: the atherosclerosis risk in communities study","volume":"105","author":"Zhao","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ajpc.2025.100928_bib0120","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/CIRCRESAHA.115.305376","article-title":"The expanding complexity of estrogen receptor signaling in the cardiovascular system","volume":"118","author":"Menazza","year":"2016","journal-title":"Circ Res"},{"issue":"16","key":"10.1016\/j.ajpc.2025.100928_bib0121","doi-asserted-by":"crossref","first-page":"8957","DOI":"10.3390\/ijms22168957","article-title":"Role of \u03b2-adrenergic receptors and estrogen in cardiac repair after myocardial infarction: an overview","volume":"22","author":"Matarrese","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpc.2025.100928_bib0122","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.685996","article-title":"Predominance of heart failure with preserved ejection fraction in postmenopausal women: intra- and extra-cardiomyocyte maladaptive alterations scaffolded by estrogen deficiency","volume":"9","author":"Adekunle","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ajpc.2025.100928_bib0123","unstructured":"Infertility | CDC. April 26, 2023. Accessed May 15, 2024. https:\/\/www.cdc.gov\/reproductivehealth\/infertility\/index.htm."},{"issue":"16","key":"10.1016\/j.ajpc.2025.100928_bib0124","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jacc.2022.02.020","article-title":"Infertility and risk of heart failure in the women's Health Initiative","volume":"79","author":"Lau","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.ajpc.2025.100928_bib0125","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.jacc.2017.03.557","article-title":"Reproductive factors and incidence of heart failure hospitalization in the women's Health Initiative","volume":"69","author":"Hall","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.ajpc.2025.100928_bib0126","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1111\/1471-0528.15394","article-title":"Recurrence of pre-eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta-analysis","volume":"125","author":"Brouwers","year":"2018","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.ajpc.2025.100928_bib0127","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/M17-2740","article-title":"Hypertensive disorders of pregnancy and maternal cardiovascular disease risk factor development","volume":"169","author":"Stuart","year":"2018","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100928_bib0128","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ahj.2008.06.042","article-title":"Cardiovascular sequelae of preeclampsia\/eclampsia: a systematic review and meta-analyses","volume":"156","author":"McDonald","year":"2008","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.ajpc.2025.100928_bib0129","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003497","article-title":"Preeclampsia and future cardiovascular health","volume":"10","author":"Wu","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"23","key":"10.1016\/j.ajpc.2025.100928_bib0130","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2021.09.1360","article-title":"Preeclampsia predicts risk of hospitalization for heart failure with preserved ejection fraction","volume":"78","author":"Williams","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ajpc.2025.100928_bib0131","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cardfail.2020.12.020","article-title":"Pregnancy associated heart failure with preserved ejection fraction: risk factors and maternal morbidity","volume":"27","author":"Briller","year":"2021","journal-title":"J Card Fail"},{"issue":"1","key":"10.1016\/j.ajpc.2025.100928_bib0132","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12884-024-06402-5","article-title":"Risk factors for pregnancy-associated heart failure with preserved ejection fraction and adverse pregnancy outcomes: a cross-sectional study","volume":"24","author":"Lee","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"10.1016\/j.ajpc.2025.100928_bib0133","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2353\/ajpath.2008.071008","article-title":"Sex differences in autoimmune disease from a pathological perspective","volume":"173","author":"Fairweather","year":"2008","journal-title":"Am J Pathol"},{"issue":"18","key":"10.1016\/j.ajpc.2025.100928_bib0134","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026411","article-title":"Outcomes following acute coronary syndrome in patients with and without rheumatic immune-mediated inflammatory diseases","volume":"11","author":"Wassif","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100928_bib0135","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jaccao.2022.11.008","article-title":"Pre-existing autoimmune disease increases the risk of cardiovascular and noncardiovascular events after immunotherapy","volume":"4","author":"Lee","year":"2022","journal-title":"JACC CardioOncology"},{"issue":"10370","key":"10.1016\/j.ajpc.2025.100928_bib0136","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0140-6736(22)02477-1","article-title":"Cardiovascular risk in systemic autoimmune diseases","volume":"401","author":"Cafaro","year":"2023","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.ajpc.2025.100928_bib0137","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/CIRCRESAHA.121.319877","article-title":"Cardiovascular implications of immune disorders in women","volume":"130","author":"Moran","year":"2022","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.ajpc.2025.100928_bib0138","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3390\/jpm12030499","article-title":"Focus on sex and gender: what we need to know in the management of rheumatoid arthritis","volume":"12","author":"Maranini","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.ajpc.2025.100928_bib0139","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3389\/fimmu.2018.00611","article-title":"Gender bias in Human systemic Lupus Erythematosus: a problem of steroid receptor action?","volume":"9","author":"Rider","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ajpc.2025.100928_bib0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11926-018-0744-2","article-title":"Gender differences in axial spondyloarthritis: women are not so lucky","volume":"20","author":"Rusman","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ajpc.2025.100928_bib0141","doi-asserted-by":"crossref","unstructured":"Packer M. Link between synovial and myocardial inflammation: conceptual framework to explain the pathogenesis of heart failure with preserved ejection fraction in patients with systemic rheumatic diseases. Published online March 7, 2020. Accessed April 4, 2024. https:\/\/www.cfrjournal.com\/articles\/link-between-synovial-and-myocardial-inflammation-conceptual-framework-explain.","DOI":"10.15420\/cfr.2019.23"},{"issue":"7","key":"10.1016\/j.ajpc.2025.100928_bib0142","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jchf.2024.04.016","article-title":"Autoimmune disorders in heart failure with preserved ejection fraction","volume":"12","author":"Tada","year":"2024","journal-title":"JACC Heart Fail"},{"issue":"18","key":"10.1016\/j.ajpc.2025.100928_bib0143","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1093\/cvr\/cvac132","article-title":"Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies","volume":"118","author":"de Wit","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ajpc.2025.100928_bib0144","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canep.2016.01.003","article-title":"Obesity and cancer: an update of the global impact","volume":"41","author":"Arnold","year":"2016","journal-title":"Cancer Epidemiol"},{"issue":"12","key":"10.1016\/j.ajpc.2025.100928_bib0145","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nrc3174","article-title":"Molecular mechanisms of cancer development in obesity","volume":"11","author":"Khandekar","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.ajpc.2025.100928_bib0146","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamaoncol.2018.5639","article-title":"Proportion of cancer cases attributable to excess body weight by US State, 2011-2015","volume":"5","author":"Islami","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ajpc.2025.100928_bib0147","unstructured":"Cancer facts for women | most common cancers in women. Accessed May 16, 2024. https:\/\/www.cancer.org\/cancer\/risk-prevention\/understanding-cancer-risk\/cancer-facts\/cancer-facts-for-women.html."},{"issue":"3","key":"10.1016\/j.ajpc.2025.100928_bib0148","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10549-022-06586-4","article-title":"Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer","volume":"193","author":"Kwan","year":"2022","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.ajpc.2025.100928_bib0149","first-page":"1","article-title":"Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy","volume":"1","author":"Han","year":"2017","journal-title":"Npj Precis Oncol"},{"issue":"10","key":"10.1016\/j.ajpc.2025.100928_bib0150","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/ejhf.2207","article-title":"The association between heart failure and incident cancer in women: an analysis of the Women's Health Initiative","volume":"23","author":"Leedy","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"17","key":"10.1016\/j.ajpc.2025.100928_bib0151","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2016.07.763","article-title":"Effect of aldosterone antagonism on exercise tolerance in heart failure with preserved ejection fraction","volume":"68","author":"Kosmala","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ajpc.2025.100928_bib0152","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.2013.905","article-title":"Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial","volume":"309","author":"Edelmann","year":"2013","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.ajpc.2025.100928_bib0153","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Bertram","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajpc.2025.100928_bib0154","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jchf.2019.01.003","article-title":"Sex differences in outcomes and responses to spironolactone in heart failure with preserved ejection fraction","volume":"7","author":"Merrill","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100928_bib0155","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/CIRCHEARTFAILURE.113.000885","article-title":"Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation","volume":"7","author":"Nakagawa","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100928_bib0156","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.119.044491","article-title":"Effects of Sacubitril-Valsartan versus valsartan in women compared with men with heart failure and preserved ejection fraction","volume":"141","author":"McMurray","year":"2020","journal-title":"Circulation"},{"issue":"9851","key":"10.1016\/j.ajpc.2025.100928_bib0157","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0140-6736(12)61227-6","article-title":"The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial","volume":"380","author":"Solomon","year":"2012","journal-title":"The Lancet"},{"issue":"19","key":"10.1016\/j.ajpc.2025.100928_bib0158","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1001\/jama.2021.18463","article-title":"Effect of Sacubitril\/Valsartan vs standard medical therapies on plasma NT-proBNP concentration and submaximal exercise capacity in patients with heart failure and preserved ejection fraction: the PARALLAX randomized clinical trial","volume":"326","author":"Pieske","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ajpc.2025.100928_bib0159","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12933-018-0775-z","article-title":"Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure","volume":"17","author":"Soga","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.ajpc.2025.100928_bib0160","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12933-019-0820-6","article-title":"SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob\/ob\u2212\/\u2212 mice","volume":"18","author":"Adingupu","year":"2019","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.ajpc.2025.100928_bib0161","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/cvr\/cvx186","article-title":"Effects of dapagliflozin on human epicardial adipose tissue: modulation of insulin resistance, inflammatory chemokine production, and differentiation ability","volume":"114","author":"D\u00edaz-Rodr\u00edguez","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"12","key":"10.1016\/j.ajpc.2025.100928_bib0162","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon Scott","year":"2022","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.ajpc.2025.100928_bib0163","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker Stefan","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajpc.2025.100928_bib0164","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt Deepak","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ajpc.2025.100928_bib0165","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/ejhf.2135","article-title":"Prevention of heart failure events with sodium\u2013glucose co-transporter 2 inhibitors across a spectrum of cardio-renal-metabolic risk","volume":"23","author":"Bhatia","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.ajpc.2025.100928_bib0166","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab"},{"issue":"10","key":"10.1016\/j.ajpc.2025.100928_bib0167","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa2108269","article-title":"Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes","volume":"385","author":"Gerstein Hertzel","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ajpc.2025.100928_bib0168","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ajpc.2025.100928_bib0169","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Mansoor","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2025.100928_bib0170","doi-asserted-by":"crossref","unstructured":"Ostrominski J.W., Lala A. Incretin-based therapies in women with obesity-related HFpEF: time to STEP into A paradigm of integrated care. J Am Coll Cardiol. 0(0). doi:10.1016\/j.jacc.2024.06.006.","DOI":"10.1016\/j.jacc.2024.06.006"},{"key":"10.1016\/j.ajpc.2025.100928_bib0171","doi-asserted-by":"crossref","unstructured":"Verma S., Butler J., Borlaug B.A., et al. Efficacy of semaglutide by sex in obesity-related heart failure with preserved ejection fraction. J Am Coll Cardiol. 0(0). doi:10.1016\/j.jacc.2024.06.001.","DOI":"10.1016\/j.jacc.2024.06.001"},{"issue":"4","key":"10.1016\/j.ajpc.2025.100928_bib0172","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/GME.0000000000002310","article-title":"Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use","volume":"31","author":"Hurtado","year":"2024","journal-title":"Menopause"},{"issue":"18","key":"10.1016\/j.ajpc.2025.100928_bib0173","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ajpc.2025.100928_bib0174","doi-asserted-by":"crossref","first-page":"e699","DOI":"10.1161\/CIR.0000000000001122","article-title":"Supervised exercise training for chronic Heart failure with preserved ejection fraction: a scientific statement from the American Heart Association and American College of Cardiology","volume":"147","author":"Sachdev","year":"2023","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ajpc.2025.100928_bib0175","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa2026141","article-title":"Physical rehabilitation for older patients hospitalized for heart failure","volume":"385","author":"Kitzman Dalane","year":"2021","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ajpc.2025.100928_bib0176","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jacc.2023.12.019","article-title":"Sex differences in association of physical activity with all-cause and cardiovascular mortality","volume":"83","author":"Ji","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2025.100928_bib0177","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jacbts.2019.12.009","article-title":"Estrogen receptor-\u03b1 non-nuclear signaling confers cardioprotection and is essential to cGMP-PDE5 inhibition efficacy","volume":"5","author":"Fukuma","year":"2020","journal-title":"JACC Basic Transl Sci"},{"issue":"6","key":"10.1016\/j.ajpc.2025.100928_bib0178","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1172\/JCI70731","article-title":"PDE5 inhibitor efficacy is estrogen dependent in female heart disease","volume":"124","author":"Sasaki","year":"2014","journal-title":"J Clin Invest"},{"issue":"13","key":"10.1016\/j.ajpc.2025.100928_bib0179","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"The women's Health Initiative hormone therapy trials: update and overview of health outcomes during the intervention and post-stopping phases","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA J Am Med Assoc"},{"issue":"11","key":"10.1016\/j.ajpc.2025.100928_bib0180","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1097\/GME.0000000000001233","article-title":"Evolution of postmenopausal hormone therapy between 2002 and 2009","volume":"25","author":"Ettinger","year":"2018","journal-title":"Menopause"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100928_bib0181","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1210\/jc.2012-4070","article-title":"Where are we 10 years after the Women's Health Initiative?","volume":"98","author":"Lobo","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"10.1016\/j.ajpc.2025.100928_bib0182","first-page":"1115","article-title":"Postmenopausal hormone therapy for cardiovascular health: the evolving data","volume":"107","author":"Gersh","year":"2021","journal-title":"Heart Br Card Soc"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100928_bib0183","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1210\/clinem\/dgab042","article-title":"Menopausal hormone therapy and cardiovascular Disease: the role of formulation, dose, and route of delivery","volume":"106","author":"Shufelt","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ajpc.2025.100928_bib0184","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1172\/JCI38291","article-title":"Non-nuclear estrogen receptor \u03b1 signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice","volume":"120","author":"Chambliss","year":"2010","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.ajpc.2025.100928_bib0185","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/154099903765448853","article-title":"Hormone replacement therapy and the risk of incident congestive heart failure: the cardiovascular health study","volume":"12","author":"Rea","year":"2003","journal-title":"J Womens Health"},{"issue":"10","key":"10.1016\/j.ajpc.2025.100928_bib0186","doi-asserted-by":"crossref","first-page":"e70029","DOI":"10.1002\/pds.70029","article-title":"The impact of hormone replacement therapy on the risk of heart failure in postmenopausal women: a meta-analysis of clinical and observational studies","volume":"33","author":"Arayici","year":"2024","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"22","key":"10.1016\/j.ajpc.2025.100928_bib0187","doi-asserted-by":"crossref","first-page":"e841","DOI":"10.1161\/CIR.0000000000000767","article-title":"Addressing social determinants of health in the care of patients with heart failure: a scientific statement from the American Heart Association","volume":"141","author":"White-Williams","year":"2020","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ajpc.2025.100928_bib0188","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/ehf2.13848","article-title":"Patient profile and outcomes associated with follow-up in specialty vs. primary care in heart failure","volume":"9","author":"Lindberg","year":"2022","journal-title":"ESC Heart Fail"},{"issue":"11","key":"10.1016\/j.ajpc.2025.100928_bib0189","doi-asserted-by":"crossref","first-page":"e13843","DOI":"10.1111\/eci.13843","article-title":"Social determinants of health and cardiovascular outcomes in patients with heart failure","volume":"52","author":"Vinter","year":"2022","journal-title":"Eur J Clin Invest"},{"issue":"18","key":"10.1016\/j.ajpc.2025.100928_bib0190","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2023.03.393","article-title":"2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ajpc.2025.100928_bib0191","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100452","article-title":"Automated echocardiographic detection of heart failure with preserved ejection fraction using artificial intelligence","volume":"2","author":"Akerman","year":"2023","journal-title":"JACC Adv"},{"issue":"11","key":"10.1016\/j.ajpc.2025.100928_bib0192","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.jcmg.2021.05.005","article-title":"AI-assisted echocardiographic prescreening of heart failure with preserved ejection fraction on the basis of intrabeat dynamics","volume":"14","author":"Chiou","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.ajpc.2025.100928_bib0193","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007138","article-title":"Machine learning analysis of left ventricular function to characterize heart failure with preserved ejection fraction","volume":"11","author":"Sanchez-Martinez","year":"2018","journal-title":"Circ Cardiovasc Imag"},{"issue":"10","key":"10.1016\/j.ajpc.2025.100928_bib0194","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.jcmg.2021.04.010","article-title":"Deep-learning models for the echocardiographic assessment of diastolic dysfunction","volume":"14","author":"Pandey","year":"2021","journal-title":"JACC Cardiovasc Imag"},{"issue":"2","key":"10.1016\/j.ajpc.2025.100928_bib0195","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ejhf.3115","article-title":"Artificial intelligence methods for improved detection of undiagnosed heart failure with preserved ejection fraction","volume":"26","author":"Wu","year":"2024","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.ajpc.2025.100928_bib0196","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/d41573-022-00158-3","article-title":"Accelerating therapeutic discoveries for heart failure: a new public\u2013private partnership","volume":"21","author":"Shah","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"18","key":"10.1016\/j.ajpc.2025.100928_bib0197","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.jacc.2018.02.070","article-title":"Participation of women in clinical trials supporting FDA approval of cardiovascular drugs","volume":"71","author":"Scott","year":"2018","journal-title":"J Am Coll Cardiol"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725000017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725000017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T21:00:04Z","timestamp":1760648404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667725000017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":197,"alternative-id":["S2666667725000017"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.100928","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Underpinnings of heart failure with preserved ejection fraction in women - From prevention to improving function. A co-publication with the American Journal of Preventive Cardiology and the Journal of Cardiac Failure","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.100928","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier BV and Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100928"}}